abstract        background and objective: aluminum salts are among the most common useful additive compounds in preparation of human and animal vaccines. aluminum phosphate and aluminum hydroxide are two additives that show good immunoadjuvant effects with many antigens. aluminum-containing vaccines lead to a better and longer immune response compared to adjuvant-lacking vaccines. the chromogen...

introduction: viral hepatitis is one of the causes of premature death in world peoples, according to who reports, five percentage of people are carrier, lethal from this disease is 1%, therefore about 1-1.5 million people each year die from complications of this disease. this disease varies from an acute to chronic illness. the aim of this study was to determine the level of anti-hbs ag (hepati...

Hepatitis B virus (HBV) is a serious global health problem. The development of a safe and effective vaccinewould help infection prevention. Previous hepatitis B vaccine production involved the isolation of the noninfectious particle from chronic HBV carriers. DNA recombinant technology has been used for vaccineproduction without having been contaminated with blood-born infectious ag...

hepatitis b vaccination coverage among teaching hospitals workers in the urmia city ali gholami, tahereh alinia , leila moosavi jahromi * received: 25 april, 2010 accepted: 27 july, 2010 abstract introduction: hepatitis b virus infection is a well recognized risk for healthcare workers (hcws). for protect hcws of hepatitis b, vaccination has been recommended. the aim of this study is survey of...

long-term protection against hepatitis b virus (hbv) is dependent on persistence of anti-hbs antibodies and/or strong immunological memory. in this study we evaluated the persistence of anti-hbs antibodies in healthy iranian children 5 years after primary vaccination and the response to a booster dose using recombinant hepatitis b vaccine. totally, 81 children who had received primary course of...

results the results of this study indicated that the overall hepatitis b vaccine acceptance rate was acceptably high. among all, 53.5% correctly identified that a vaccine to prevent hepatitis b virus infection had been available, 15% had a negative opinion, and 31.5% were neutral. the rations of all three doses of vaccination were 69.3%. conclusions among the respondents, 87% were currently mar...

To the Editor—It was with interest that we read the study by Frey et al. [1], which describes a randomized trial in which 3 manufacturing consistency lots of a combined hepatitis A and B vaccine were compared with the corresponding monovalent vaccines. The authors observed a nonsatisfactory response to the hepatitis B component in the combined vaccine. We are concerned that this report may be m...

BACKGROUND AND AIM: Hepatitis B Virus (HBV), a DNA virus with a human-only reservoir, is a worldwide public health problem. Approximately 45.0% of the world’s population is considered to live in areas of high endemicity with a lifetime risk of infection of more than 60.0%. The present study aimed to assess the level of understanding and awareness about Hepatitis B immunization among the first a...